9,408 followers
An exploratory biomarker study of the phase 3 ICON7 trial studying c-MET/VEGFR-2 co-localisation impacts on survival following #bevacizumab therapy in epithelial #ovariancancer Read it here: https://t.co/rII7IQXBQU https://t.co/iLyLtHwRNw